Literature DB >> 8291100

Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation.

R Mañez1, S Kusne, P Linden, I Gonzalez-Pinto, H Bonet, D Kramer, J J Fung, T E Starzl.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8291100      PMCID： PMC2977934          DOI： 10.1097/00007890-199401000-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.

Authors:  J Fung; K Abu-Elmagd; A Jain; R Gordon; A Tzakis; S Todo; S Takaya; M Alessiani; A Demetris; O Bronster
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness.

Authors:  K Kapasi; G P Rice
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

4.  The compromised host as sentinel chicken.

Authors:  R H Rubin
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

Review 5.  [Infectious complications in immunosuppressed patients after kidney transplantation].

Authors:  W A Scherbaum; B Zanker
Journal:  Immun Infekt       Date:  1988-02

Review 6.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

Review 7.  Immunosuppression in viral infections.

Authors:  B T Rouse; D W Horohov
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

8.  Infection in renal transplantation. The first six months.

Authors:  M Bass
Journal:  Crit Care Nurs Clin North Am       Date:  1990-03       Impact factor: 1.326

9.  Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.

Authors:  T E Starzl; A J Demetris; M Trucco; C Ricordi; S Ildstad; P I Terasaki; N Murase; R S Kendall; M Kocova; W A Rudert
Journal:  N Engl J Med       Date:  1993-03-18       Impact factor: 91.245

10.  Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.

Authors:  A J Demetris; J J Fung; S Todo; J McCauley; A Jain; S Takaya; M Alessiani; K Abu-Elmagd; D H Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939
  10 in total
  6 in total

Review 1.  Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.

Authors:  Bradley S Podd; Dennis W Simon; Santiago Lopez; Andrew Nowalk; Rajesh Aneja; Joseph A Carcillo
Journal:  Pediatr Clin North Am       Date:  2017-08-18       Impact factor: 3.278

2.  A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report.

Authors:  A B Jain; I Hamad; J Rakela; F Dodson; D Kramer; J Demetris; J McMichael; T E Starzl; J J Fung
Journal:  Transplantation       Date:  1998-11-27       Impact factor: 4.939

Review 3.  Innate Immune Cells in Immune Tolerance After Liver Transplantation.

Authors:  Hongting Huang; Yefeng Lu; Tao Zhou; Guangxiang Gu; Qiang Xia
Journal:  Front Immunol       Date:  2018-11-09       Impact factor: 7.561

4.  High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction.

Authors:  Fang Chen; Xiao-Yun Pang; Chuan Shen; Long-Zhi Han; Yu-Xiao Deng; Xiao-Song Chen; Jian-Jun Zhang; Qiang Xia; Yong-Bing Qian
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

5.  A Supraglottic Pseudotumor in an Immunocompromised Patient with Nephrotic Syndrome, Herpes Zoster, and a Cytomegalovirus Infection.

Authors:  Tetsu Akimoto; Tomoyuki Yamazaki; Osamu Saito; Shigeaki Muto; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2016-08-08

6.  Is this critically ill patient immunocompromised?

Authors:  Frédéric Pène; Peter Pickkers; Richard S Hotchkiss
Journal:  Intensive Care Med       Date:  2015-12-02       Impact factor: 17.440
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.